Embolization of high-flow craniofacial vascular malformations with onyx

dc.contributor.authorArat, A.
dc.contributor.authorCil, B. E.
dc.contributor.authorVargel, İ.
dc.contributor.authorTürkbey, B.
dc.contributor.authorCanyigit, M.
dc.contributor.authorPeynircioglu, B.
dc.contributor.authorArat, Y. O.
dc.date.accessioned2020-06-25T17:43:39Z
dc.date.available2020-06-25T17:43:39Z
dc.date.issued2007
dc.description44th Annual Meeting of the American-Society-of-Neuroradiology -- APR 29-MAY 05, 2006 -- San Diego, CA
dc.descriptionarat, anil/0000-0001-7122-4675; CANYIGIT, MURAT/0000-0003-3188-0082; Peynircioglu, Bora/0000-0002-1457-4721
dc.description.abstractBACKGROUND AND PURPOSE: Various techniques and materials have been used for the endovascular treatment of craniofacial high-flow arteriovenous vascular malformations, because their rarity precludes standardization of their treatment. The aim of this retrospective review is to assess Onyx as the primary embolic agent in the treatment of these vascular malformations. MATERIALS AND METHODS: Six patients with arteriovenous fistulas and 3 with arteriovenous malformations (AVMs) of the head and neck region were treated with intra-arterial (IA)/direct percutaneous injections of Onyx. Adjunctive maneuvers used during embolization included external compression of the arterial feeders or venous outflow (6 patients), balloon assist (4 patients), and direct embolization of the draining vein remote to the fistula site (1 patient). n-butyl-2-cyanoacrylate (n-BCA) was used in addition to Onyx for rapid induction of thrombosis in a large venous pouch (1 patient) and for cost containment purposes (I patient). Four patients were treated surgically after the embolization. RESULTS: There were no neurologic complications secondary to the embolization procedure. The arteriovenous shunt was eliminated in all of the fistulous lesions and 2 of the 3 AVMs. The embolization was incomplete in 1 patient with a large AVM who declined further enclovascular or surgical procedures. Untoward events included 2 instances of catheter entrapment (of 9 IA injections), blackish skin discoloration necessitating surgical revision in 1 patient, and difficulty of balloon deflation/wire withdrawal during a balloon-assisted embolization. CONCLUSION: Onyx appears to be a safe and effective liquid emboiic agent for use in the treatment of craniofacial high-flow vascular malformations with distinct advantages and disadvantages compared with n-BCA.en_US
dc.description.sponsorshipAmer Soc Neuroradiolen_US
dc.identifier.citationclosedAccessen_US
dc.identifier.doi10.3174/ajnr.A0547
dc.identifier.endpage1414en_US
dc.identifier.issn0195-6108
dc.identifier.issue7en_US
dc.identifier.pmid17698554
dc.identifier.scopus2-s2.0-34548190968
dc.identifier.scopusqualityQ1
dc.identifier.startpage1409en_US
dc.identifier.urihttps://doi.org10.3174/ajnr.A0547
dc.identifier.urihttps://hdl.handle.net/20.500.12587/3845
dc.identifier.volume28en_US
dc.identifier.wosWOS:000249278700042
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherAmer Soc Neuroradiologyen_US
dc.relation.ispartofAmerican Journal Of Neuroradiology
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleEmbolization of high-flow craniofacial vascular malformations with onyxen_US
dc.typeConference Object

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
[ X ]
İsim:
Embolization of high-flow craniofacial vascular malformations with onyx.pdf
Boyut:
727.64 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin/Full Text